Cover Image
市場調查報告書

藥物濫用檢測的全球市場預測 2017-2027年:員工檢驗·非人為檢驗·合理的檢驗·事故後檢驗

Global Drug of Abuse Testing Market Report 2017-2027: Employment Testing, Random Testing, Reasonable Testing, Post-Accident Testing

出版商 Visiongain Ltd 商品編碼 553820
出版日期 內容資訊 英文 165 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
藥物濫用檢測的全球市場預測 2017-2027年:員工檢驗·非人為檢驗·合理的檢驗·事故後檢驗 Global Drug of Abuse Testing Market Report 2017-2027: Employment Testing, Random Testing, Reasonable Testing, Post-Accident Testing
出版日期: 2017年07月21日 內容資訊: 英文 165 Pages
簡介

全球藥物濫用檢測市場規模在2016年為44億美金,預計在預測期間的前期中將以4.9%的年複合成長率 (CAGR) 擴大。該市場就類別來看,員工檢驗市場佔最大多數,2016年佔39.3%的市場佔有率。

本報告涵括全球藥物濫用檢測市場,提供市場概要,主要的子市場收益預測,主要地區·國家市場之收益預測,市場成長的影響因素,及主要企業等系統性資訊。

第1章 調查概要

第2章 藥物濫用檢測市場簡介

  • 藥物濫用檢測是什麼?
  • 藥物濫用檢測的用途是?
  • 檢驗結果代表什麼?

第3章 全球藥物濫用檢測市場

  • 全球藥物濫用檢測市場預測
  • 波特的五力分析
  • 新加入廠商者的威脅
  • 替代產品/服務的威脅
  • 供給者 (賣主)的談判力
  • 購買者 (買主)的談判力
  • 現有企業的敵對關係
  • 全球藥物濫用檢測市場上促進要素·抑制因素

第4章 全球藥物濫用檢測市場:各類型

  • 藥物濫用檢測市場佔有率:各類型
    • 員工檢驗:市場預測
    • 非人為檢驗:市場預測
    • 合理的檢驗:市場預測
    • 事故後檢驗:市場預測

第5章 全球藥物濫用檢測市場:樣品類別

  • 藥物濫用檢測市場佔有率:樣品類別
    • 唾液:市場預測
    • 呼氣:市場預測
    • 尿:市場預測
    • 血液:市場預測
    • 毛髮:市場預測
    • 汗:市場預測

第6章 全球藥物濫用檢測市場:各用途

  • 全球藥物濫用檢測市場:各用途
    • 學校:市場預測
    • 醫院:市場預測
    • 政府·民間經營者:市場預測
    • 其他:市場預測

第7章 主要國家的藥物濫用檢測市場預測

  • 北美:市場分析
  • 南美:市場分析
  • 歐洲:市場分析
  • 亞太地區 (日本以外) :市場分析
  • 日本:市場分析
  • MEA (中東·非洲) :市場分析

第8章 全球藥物濫用檢測市場上主要企業

  • Abbott Industries
  • Danaher Corporation
  • F. Hoffmann-La Roche AG (Roche Diagnostics)
  • Bio-Rad Laboratories, Inc.
  • Express Diagnostics International Inc.
  • Quest Diagnostics Incorporated
  • Siemens Aktiengesellschaft
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • BioMerieux, Inc.

第9章 結論

圖表

目錄
Product Code: PHA0215

Title:
Global Drug of Abuse Testing Market Report 2017-2027
Employment Testing, Random Testing, Reasonable Testing, Post-Accident Testing, Saliva, Breath, Urine, Blood, Hair, Sweat, Schools and Educational Institutes, Hospitals and Healthcare Units, Government and Private Departments and Others.

The global drug of abuse testing market was valued at $4.4bn in 2016 and is projected to grow at a CAGR of 4.9% in the first half of the forecast period. The market is dominated by the Employment Testing submarket which held 39.3% share of that market in 2016.

How this report will benefit you:

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 165 page report you will receive 78 tables and 71 figures - all unavailable elsewhere.

The 165-page report provides clear detailed insight into the global drug of abuse testing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Drug of Abuse Testing Market forecasts from 2017-2027
  • Revenue forecast for drug of abuse testing market by Type:
    • Employment Testing
    • Random Testing
    • Reasonable Testing
    • Post-Accident Testing
    • Other

Each submarket is further divided by region: North America, Latin America, Europe, APEJ, Japan and MEA

  • Revenue forecast for drug of abuse testing market by Sample Type:
    • Saliva
    • Breath
    • Urine
    • Blood
    • Hair
    • Sweat

Each submarket is further divided by region: North America, Latin America, Europe, APEJ, Japan and MEA

  • Revenue forecast for drug of abuse testing market by Application:
    • Schools and Educational Institutes
    • Hospitals and Healthcare Units
    • Government and Private Departments
    • Others

Each submarket is further divided by region: North America, Latin America, Europe, APEJ, Japan and MEA

  • This report provides individual revenue forecasts to 2027 for these regional and national markets:
    • North America: the US and Canada
    • Latin America: Mexico, Brazil, Argentina
    • Europe: Germany, France, UK, Italy, Spain, Rest of Europe
    • APEJ: China, India, Australia, Rest of APEJ
    • MEA: GCC Countries, South Africa, Rest of MEA
    • Japan

Each regional market is further divided by type, sample type and application.

  • This report discusses the leading companies in the global drug of abuse testing market:
    • Abbott
    • Danaher
    • Roche
    • Siemens
    • Biomerieux, Inc.
    • Bio-Rad Laboratories
    • Express Diagnostics International
    • Quest Diagnostics Incorporated
    • Thermo Fisher Scientific
    • Agilent Technologies, Inc.
  • This report discusses the drivers, restraints as well as porter's five forces analysis of the global drug of abuse testing market

Visiongain's study is intended for anyone requiring commercial analyses for the global drug of abuse testing market. You find data, trends and predictions.

Buy our report today Global Drug of Abuse Testing Market Report 2017-2027: Employment Testing, Random Testing, Reasonable Testing, Post-Accident Testing, Saliva, Breath, Urine, Blood, Hair, Sweat, Schools and Educational Institutes, Hospitals and Healthcare Units, Government and Private Departments and Others.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Drug of Abuse Testing Ingredients Market Overview
  • 1.2. Why You Should Read This Report
  • 1.3. Global Drug of Abuse Testing Market Segmentation
  • 1.4. How This Report Delivers
  • 1.5. Key Questions Answered by This Analytical Report Include:
  • 1.6. Who is This Report for?
  • 1.7. Methodology
    • 1.7.1. Primary Research
    • 1.7.2. Secondary Research
    • 1.7.3. Market Evaluation& Forecasting Methodology
  • 1.8. Frequently Asked Questions (FAQ)
  • 1.9. Associated Visiongain Reports
  • 1.10. About visiongain

2. Introduction to the Drug of Abuse Testing market

  • 2.1. What is Drug of Abuse Testing?
  • 2.2. What is Drug of Abuse Testing Used For?
  • 2.3. What Does the Test Result Mean?

3. Global Drug of Abuse Testing Market 2017-2027

  • 3.1. Global Drug of Abuse Testing Market Forecast 2017-2027
  • 3.2. Porters Five Forces Analysis
  • 3.3. Threat of New Entrants
  • 3.4. Threat of Substitutes
  • 3.5. Bargaining Power of Suppliers
  • 3.6. Bargaining Power of Buyers
  • 3.7. Competitive Rivalry
  • 3.8. Global Drug of Abuse Testing Market Drivers and Restraints 2017
    • 3.8.1. Drivers
    • 3.8.2. Increasing production and trafficking of illegal drugs
    • 3.8.3. Increase in drug related deaths and accidents
    • 3.8.4. Increasing demand for high safety and productivity of employees
    • 3.8.5. Mandate drug testing policies
    • 3.8.6. Restraints
    • 3.8.7. Duping the drug of abuse test

4. Global Drug of Abuse Testing Market by Type, 2017-2027

  • 4.1. Drug of Abuse Testing Market Shares by Type
    • 4.1.1. Employment Testing Submarket Forecast 2017-2027
    • 4.1.2. Random Testing Submarket Forecast 2017-2027
    • 4.1.3. Reasonable Testing Submarket Forecast 2017-2027
    • 4.1.4. Post-Accident Testing Submarket Forecast 2017-2027

5. Global Drug of Abuse Testing Market by Sample Type, 2017-2027

  • 5.1. Drug of Abuse Testing Market Shares by Sample Type
    • 5.1.1. Saliva Sample Type Submarket Forecast 2017-2027
    • 5.1.2. Breath Sample Type Submarket Forecast 2017-2027
    • 5.1.3. Urine Sample Type Submarket Forecast 2017-2027
    • 5.1.4. Blood Sample Type Submarket Forecast 2017-2027
    • 5.1.5. Hair Sample Type Submarket Forecast 2017-2027
    • 5.1.6. Sweat Sample Type Submarket Forecast 2017-2027

6. Global Drug of Abuse Testing Market by Application, 2017-2027

  • 6.1. Drug of Abuse Testing Market Shares by Application
    • 6.1.1. Schools and Educational Institutes Submarket Forecast 2017-2027
    • 6.1.2. Hospitals and Healthcare Units Submarket Forecast 2017-2027
    • 6.1.3. Government and Private Departments Submarket Forecast 2017-2027
    • 6.1.4. Other Submarket Forecast 2017-2027

7. Leading National Drug of Abuse Testing Markets Forecast 2017-2027

  • 7.1. North America Drug of Abuse Testing Market Regional Analysis
  • 7.2. Latin America Drug of Abuse Testing Market Regional Analysis
  • 7.3. Europe Drug of Abuse Testing Market Regional Analysis
  • 7.4. APEJ Drug of Abuse Testing Market Regional Analysis
  • 7.5. Japan Drug of Abuse Testing Market Regional Analysis
  • 7.6. MEA Drug of Abuse Testing Market Regional Analysis

8. Leading Players in Global Drug of Abuse Testing Market 2017-2027

  • 8.1. Abbott Industries
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Product Portfolio
    • 8.1.4. Business performance
    • 8.1.5. Key Developments
  • 8.2. Danaher Corporation
    • 8.2.1. Company overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Product portfolio
    • 8.2.4. Business performance
    • 8.2.5. Key Developments
  • 8.3. F. Hoffmann-La Roche AG (Roche Diagnostics)
    • 8.3.1. Company overview
    • 8.3.2. Company snapshot
    • 8.3.3. Operating business segments
    • 8.3.4. Product portfolio
    • 8.3.5. Business Performance
    • 8.3.6. Key Developments
  • 8.4. Bio-Rad Laboratories, Inc.
    • 8.4.1. Company overview
    • 8.4.2. Company snapshot
    • 8.4.3. Operating business segments
    • 8.4.4. Product portfolio
    • 8.4.5. Business Performance
    • 8.4.6. Key Developments
  • 8.5. Express Diagnostics International Inc.
    • 8.5.1. Company overview
    • 8.5.2. Operating business segments
    • 8.5.3. Business Performance
    • 8.5.4. Key Developments
  • 8.6. Quest Diagnostics Incorporated
    • 8.6.1. Company overview
    • 8.6.2. Company snapshot
    • 8.6.3. Operating business segments
    • 8.6.4. Product portfolio
    • 8.6.5. Business Performance
    • 8.6.6. Key Developments
  • 8.7. Siemens Aktiengesellschaft
    • 8.7.1. Company overview
    • 8.7.2. Company snapshot
    • 8.7.3. Operating segments
    • 8.7.4. Product portfolio
    • 8.7.5. Business Performance
    • 8.7.6. Key Developments
  • 8.8. Thermo Fisher Scientific Inc.
    • 8.8.1. Company overview
    • 8.8.2. Company snapshot
    • 8.8.3. Operating business segments
    • 8.8.4. Product portfolio
    • 8.8.5. Business Performance
    • 8.8.6. Key Developments
  • 8.9. Agilent Technologies Inc.
    • 8.9.1. Company overview
    • 8.9.2. Company snapshot
    • 8.9.3. Operating business segments
    • 8.9.4. Product portfolio
    • 8.9.5. Business Performance
    • 8.9.6. Key Developments
  • 8.10. BioMerieux, Inc.
    • 8.10.1. Company Overview:
    • 8.10.2. Company snapshot
    • 8.10.3. Business Performance
    • 8.10.4. Key Developments

9. Conclusion

  • Appendices
  • Visiongain Associated Report
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain report evaluation form

List of Tables

  • Table 3.1. Global Drug of Abuse Testing Market Forecast ($M, AGR%, CAGR%) 2016-2027
  • Table 4.1. Global Drug of Abuse Testing Market Forecast by Type: ($M, AGR%, CAGR%) 2016-2027
  • Table 4.2. Employment Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027
  • Table 4.3. Random Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027
  • Table 4.4. Reasonable Testing Submarket Forecast by Region ($M, AGR%, CAGR%) 2016-2027
  • Table 4.5. Post-Accident Testing Submarket Forecast by Region ($M, AGR%, CAGR%) 2016-2027
  • Table 5.1. Global Drug of Abuse Testing Market Forecast by Sample Type ($M, AGR%, CAGR%) 2016-2027
  • Table 5.2. Saliva Testing Submarket Forecast by Region ($M, AGR%, CAGR%) 2016-2027
  • Table 5.3. Breath Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027
  • Table 5.4. Urine Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027
  • Table 5.5. Blood Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027
  • Table 5.6. Hair Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027
  • Table 5.7. Sweat Testing Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027
  • Table 6.1. Global Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027
  • Table 6.2. Schools and Educational Institutes Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027
  • Table 6.3. Hospitals and Healthcare Units Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027
  • Table 6.4. Government and Private Departments Submarket Forecast by Region: ($M, AGR%) 2016-2027
  • Table 6.5. Other Submarket Forecast by Region: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.1. Global Drug of Abuse Testing Market Forecast by Region: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.2. North America Drug of Abuse Testing Market Forecast by Type: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.3. North America Drug of Abuse Testing Market Forecast by Sample Type: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.4. North America Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.5. North America Drug of Abuse Testing Market Forecast by Country: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.6. Latin America Drug of Abuse Testing Market Forecast by Type: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.7. Latin America Drug of Abuse Testing Market Forecast by Sample Type: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.8. Latin America Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.9. Latin America Drug of Abuse Testing Market Forecast by Country: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.10. Europe Drug of Abuse Testing Market Forecast by Type: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.11. Europe Drug of Abuse Testing Market Forecast by Sample Type: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.12. Europe Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.13. Europe Drug of Abuse Testing Market Forecast by Country: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.14. APEJ Drug of Abuse Testing Market Forecast by Type: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.15. APEJ Drug of Abuse Testing Market Forecast by Sample Type: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.16. APEJ Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.17. APEJ Drug of Abuse Testing Market Forecast by Country: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.18. Japan Drug of Abuse Testing Market Forecast by Type ($M, AGR%, CAGR%) 2016-2027
  • Table 7.19. Japan Drug of Abuse Testing Market Forecast by Sample Type ($M, AGR%, CAGR%) 2016-2027
  • Table 7.20. Japan Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.21. MEA Drug of Abuse Testing Market Forecast by Type: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.22. MEA Drug of Abuse Testing Market Forecast by Sample Type: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.23. MEA Drug of Abuse Testing Market Forecast by Application: ($M, AGR%, CAGR%) 2016-2027
  • Table 7.24. MEA Drug of Abuse Testing Market Forecast by Country: ($M, AGR%, CAGR%) 2016-2027
  • Table 8.1. Company Snapshot: Abbott Laboratories
  • Table 8.2. Business Segments: Abbott Laboratories
  • Table 8.3. Product Portfolio: Abbott Laboratories
  • Table 8.4. Key Developments: Abbott Laboratories
  • Table 8.5. Company Snapshot: Danaher Corporation
  • Table 8.6. Business Segments: Danaher Corporation
  • Table 8.7. Product Portfolio: Danaher Corporation
  • Table 8.8. Key Developments: Danaher Corporation
  • Table 8.9. Company Snapshot: F. Hoffmann-La Roche Ag
  • Table 8.10. Business Segments: F. Hoffmann-La Roche Ag
  • Table 8.11. Product Portfolio: F. Hoffmann-La Roche Ag
  • Table 8.12. Key Developments: F. Hoffmann-La Roche Ag
  • Table 8.13. Company Snapshots: Bio-Rad Laboratories, Inc.
  • Table 8.14. Business Segments: Bio-Rad Laboratories, Inc.
  • Table 8.15. Product Portfolio: Bio-Rad Laboratories, Inc.
  • Table 8.16. Key Developments: Bio-Rad Laboratories, Inc.
  • Table 8.17. Company Snapshot: Express Diagnostics International Inc.
  • Table 8.18. Business Segments: Express Diagnostics International Inc.
  • Table 8.19. Key Developments: Express Diagnostics International Inc.
  • Table 8.20. Company Snapshot: Quest Diagnostics Incorporated
  • Table 8.21. Business Segments: Quest Diagnostics Incorporated
  • Table 8.22. Product Portfolio: Quest Diagnostics Incorporated
  • Table 8.23. Key Developments: Quest Diagnostics Incorporated
  • Table 8.24. Company Snapshots: Siemens Ag
  • Table 8.25. Business Segments: Siemens Ag
  • Table 8.26. Product Portfolio: Siemens Ag
  • Table 8.27. Key Developments: Siemens Ag
  • Table 8.28. Key Developments: Thermo Fisher Scientific Inc.
  • Table 8.29. Operating Segments: Thermo Fisher Scientific Inc.
  • Table 8.30. Product Portfolio: Thermo Fisher Scientific Inc.
  • Table 8.31. Key Developments: Thermo Fisher Scientific Inc.
  • Table 8.32. Company Snapshot: Agilent Technologies Inc.
  • Table 8.33. Business Segments: Agilent Technologies Inc.
  • Table 8.34. Product Portfolio: Agilent Technologies Inc.
  • Table 8.35. Key Developments: Agilent Technologies Inc.
  • Table 8.36. Company Snapshot: Biomerieux, Inc.

List of Figure

  • Figure 1.2. Global Drug of Abuse Testing Market Segmentation
  • Figure 4.1. Global Drug of Abuse Testing Market by Type: Growth Rate Forecast (AGR %) 2017-2027
  • Figure 4.2. Global Drug of Abuse Testing Market Shares by Type: (% Share), 2016
  • Figure 4.3. Global Drug of Abuse Testing Market Shares by Type: (% Share), 2022
  • Figure 4.4. Global Drug of Abuse Testing Market Shares by Type: (% Share), 2027
  • Figure 4.5. Employment Testing Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 4.6. Random Testing Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 4.7. Reasonable Testing Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 4.8. Post-Accident Testing Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 5.1. Drug of Abuse Testing Market by Sample Type: Growth Rate Forecast: (AGR %), 2017-2027
  • Figure 5.2. Global Drug of Abuse Testing Market Shares by Sample Type: (% Share), 2016
  • Figure 5.3. Global Drug of Abuse Testing Market Shares by Sample Type: (% Share), 2022
  • Figure 5.4. Global Drug of Abuse Testing Market Shares by Sample Type: (% Share), 2027
  • Figure 5.5. Saliva Testing Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 5.6. Breath Testing Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 5.7. Urine Testing Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 5.8. Blood Testing Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 5.9. Hair Testing Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 5.10. Sweat Testing Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 6.1. Drug of Abuse Testing Market by Application: Growth Rate Forecast (AGR %), 2017-2027
  • Figure 6.2. Global Drug of Abuse Testing Market Shares by Application: (% Share), 2016
  • Figure 6.3. Global Drug of Abuse Testing Market Shares by Application: (% Share), 2022
  • Figure 6.4. Global Drug of Abuse Testing Market Shares by Application: (% Share), 2027
  • Figure 6.5. Schools and Educational Institutes Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 6.6. Hospitals and Healthcare Units Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 6.7. Government and Private Departments Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 6.8. Other Submarket Forecast ($M, AGR%), 2017-2027
  • Figure 7.1. Drug of Abuse Testing Market by Region: Growth Rate Forecast (AGR %), 2017-2027
  • Figure 7.2. North America Drug of Abuse Testing Market Shares by Country: (% Share), 2016
  • Figure 7.3. North America Drug of Abuse Testing Market Shares by Country: (% Share), 2022
  • Figure 7.4. North America Drug of Abuse Testing Market Shares by Country: (%), 2027
  • Figure 7.5. Latin America Drug of Abuse Testing Market Shares by Country: (% Share), 2016
  • Figure 7.6. Latin America Drug of Abuse Testing Market Shares by Country: (% Share), 2022
  • Figure 7.7. Latin America Drug of Abuse Testing Market Shares by Country: (% Share), 2027
  • Figure 7.8. Europe Drug of Abuse Testing Market Shares by Country: (% Share), 2016
  • Figure 7.9. Europe Drug of Abuse Testing Market Shares by Country: (% Share), 2022
  • Figure 7.10. Europe Drug of Abuse Testing Market Shares by Country: (% Share), 2027
  • Figure 7.11. APEJ Drug of Abuse Testing Market Shares by Country: (% Share), 2016
  • Figure 7.12. APEJ Drug of Abuse Testing Market Shares by Country: (% Share), 2022
  • Figure 7.13. APEJ Drug of Abuse Testing Market Shares by Country: (% Share), 2027
  • Figure 7.14. MEA Drug of Abuse Testing Market Shares by Country: (% Share), 2016
  • Figure 7.15. MEA Drug of Abuse Testing Market Shares by Country: (% Share), 2022
  • Figure 7.16. MEA Drug of Abuse Testing Market Shares by Country: (% Share), 2027
  • Figure 8.1. Abbott: Net Sales, 2014-2016 ($Million)
  • Figure 8.2. Abbott: Revenue by Segment, 2016 (%)
  • Figure 8.3. Abbott: Revenue by Geography, 2016 (%)
  • Figure 8.4. Danaher Corporation: Net Sales, 2014-2016 ($Million)
  • Figure 8.5. Danaher Corporation: Revenue by Segment, 2016 (%)
  • Figure 8.6. Danaher Corporation: Revenue by Geography, 2016 (%)
  • Figure 8.7. F. Hoffmann-La Roche Ag: Net Sales, 2014-2016 ($Million)
  • Figure 8.8. F. Hoffmann-La Roche Ag: Revenue by Segment (%)
  • Figure 8.9. F. Hoffmann-La Roche Ag: Revenue by Geography (%)
  • Figure 8.10. Bio-Rad Laboratories, Inc.: Net Sales, 2014-2016 ($Million)
  • Figure 8.11. Bio-Rad Laboratories, Inc.: Revenue Share by Segment, 2016 (%)
  • Figure 8.12. Bio-Rad Laboratories, Inc.: Revenue Share by Segment, 2016 (%)
  • Figure 8.13. Quest Diagnostics Incorporated: Net Sales, 2014-2016 ($ Million)
  • Figure 8.14. Quest Diagnostics Incorporated: Revenue Share by Segment, 2016 (%)
  • Figure 8.15. Siemens Ag: Net Sales, 2014-2016 ($Million)
  • Figure 8.16. Siemens Ag: Revenue Share by Segment, 2016 (%)
  • Figure 8.16. Siemens Ag: Revenue Share by Geography, 2016 (%)
  • Figure 8.18. Thermo Fisher: Net Sales, 2014-2016 ($Million)
  • Figure 8.19. Thermo Fisher: Revenue Share by Segment, 2016 (%)
  • Figure 8.20. Thermo Fisher: Revenue Share by Geography, 2016 (%)
  • Figure 8.21. Agilent Technologies Inc.: Net Sales, 2014-2016 ($Million)
  • Figure 8.22. Agilent Technologies Inc.: Revenue by Segment, 2016 (%)
  • Figure 8.23. Agilent Technologies Inc.: Revenue by Geography, 2016 (%)
  • Figure 8.24. Biomeriux: Revenue by Geography (%)
  • Figure 9.1. Global Drug of Abuse Testing Market Shares by Type Forecast: (% Share), 2016
  • Figure 9.2. Global Drug of Abuse Testing Market Shares by Sample Type: (% Share), 2016
  • Figure 9.3. Leading Drug of Abuse Testing Application Submarkets Shares by Application: (% Share), 2016
  • Figure 9.4. Leading Drug of Abuse Testing Regional Submarkets Shares by Country: (% Share), 2016

Companies Listed

  • Abbott
  • Agilent Technologies, Inc.
  • Alere
  • Ariosa Diagnostics, Inc.
  • BioMerieux, Inc.
  • Bio-Rad Laboratories
  • Biotest AG
  • Cepheid
  • Chugai
  • Danahere
  • Express Diagnostics Global, Ltd. (EDG)
  • Express Diagnostics International, Inc.
  • GeneWEAVE, Inc.
  • International Association of Athletics Federations (IAAF)
  • Karolinska Institute
  • Quest Diagnostics Incorporated
  • Roche
  • Siemens
  • Society of Hair Testing
  • Thermo Fisher Scientific, Inc.
  • U.S. Anti-Doping Agency (USADA)
  • U.S. Department of Education
  • U.S. Department of Transportation
  • World Anti-Doping Agency (WADA)
Back to Top